Miriam Redrado

Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)

Josep M. Piulats, Enrique Espinosa, Luis de la Cruz‐Merino et al. · Journal of Clinical Oncology · 2021 · 245 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade

Daniel Ajona, Sergio Ortiz‐Espinosa, Teresa Lozano et al. · Nature Cancer · 2020 · 143 citations

Medicine, Cancer Biology, Oncology +16

Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity

Clément Anfray, Francesco Mainini, Elisabeth Digifico et al. · Journal for ImmunoTherapy of Cancer · 2021 · 94 citations · Full text

Life Sciences, Immunology, Oncology +17

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

Esther Redín, Irati Garmendia, Teresa Lozano et al. · Journal for ImmunoTherapy of Cancer · 2021 · 93 citations · Full text

Medicine, Immunology, Oncology +17

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

Roque Díaz, Paul Nguewa, Ricardo Parrondo et al. · BMC Cancer · 2010 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17